Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
Democracy that banks on the electorate
access_time 28 March 2024 5:34 AM GMT
Lessons to learn from Moscow terror attack
access_time 27 March 2024 6:10 AM GMT
Gaza
access_time 26 March 2024 4:34 AM GMT
The poison is not in words, but inside
access_time 25 March 2024 5:42 AM GMT
A witchhunt, plain and simple
access_time 23 March 2024 9:35 AM GMT
DEEP READ
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
Ukraine
access_time 16 Aug 2023 5:46 AM GMT
Ramadan: Its essence and lessons
access_time 13 March 2024 9:24 AM GMT
When ‘Jai Sree Ram’ becomes a death call
access_time 15 Feb 2024 9:54 AM GMT
exit_to_app
Homechevron_rightWorldchevron_rightWHO approves J&J Covid...

WHO approves J&J Covid vax for emergency use

text_fields
bookmark_border
WHO approves J&J Covid vax for emergency use
cancel

Geneva: The World Health Organisation (WHO) on Friday approved Johnson & Johnson's single dose Covid-19 vaccine for emergency use in all countries and for COVAX roll-out.

The decision comes on the back of the European Medicines Agency (EMA) authorisation, which was announced on Thursday.

"Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic," WHO Director-General, Tedros Adhanom Ghebreyesus, said in a statement.

"But the hope offered by these tools will not materialise unless they are made available to all people in all countries.

"I urge governments and companies to live up to their commitments and to use all solutions at their disposal to ramp up production so that these tools become truly global public goods, available and affordable to all, and a shared solution to the global crisis," he said.

The Johnson & Johnson Covid vaccine vaccine is the first to be listed by WHO as a single dose regimen, which should facilitate vaccination logistics in all countries.

Ample data from large clinical trials shared by the company also shows that the vaccine is effective in older populations.

While the vaccine needs to be stored at minus 20 degrees, which may prove challenging in some environments, it can be kept for three months at 2-8 degree Celsius and it has a long shelf life of two years.

WHO has also listed the Pfizer/BioNTech, Astrazeneca-SK Bio and Serum Institute of India vaccines for emergency use.

Show Full Article
TAGS:WHOCovid-19 vaccineJohnson& Johnson
Next Story